Intercept Pharmaceuticals, Inc.
ICPTDelisted Nov 8, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001270073
Intercept Pharmaceuticals, Inc. was delisted on Nov 8, 2023; its insiders filed their last Form 4 on Nov 13, 2023; 146 institutions reported holding it in 13F filings for Q3 2023, worth $724.6M in total; no superinvestor held it.
13F holders, Q2 2022
Institutional positions in Intercept Pharmaceuticals, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 145
- +1 vs. Q1 2022
- Shares held
- 24.3M
- +58.5K (+0.2%) vs. Q1 2022
- Total value
- $336.1M
- −$58.7M (−14.9%) vs. Q1 2022
- New holders
- 18
- 38 more added
- Sold out
- 17
- 60 more reduced
4 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ICPT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 146 | $724.6M |
| Q2 2023 | 126 | $387.3M |
| Q1 2023 | 145 | $384.5M |
| Q4 2022 | 144 | $353.4M |
| Q3 2022 | 156 | $402.4M |
| Q2 2022 | 145 | $336.1M |
| Q1 2022 | 148 | $397.3M |
| Q4 2021 | 147 | $401.3M |
| Q3 2021 | 139 | $331.5M |
| Q2 2021 | 130 | $445.9M |
| Q1 2021 | 152 | $569.7M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Intercept Pharmaceuticals, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 93,290 | $1.29M | 0.00% | −85,190−47.7% | Reduced |
| Wellington Management Group LLP | 94,376 | $1.30M | 0.00% | 00.0% | Unchanged |
| Ameriprise Financial Inc | 95,111 | $1.31M | 0.00% | +7,990+9.2% | Added |
| Connor, Clark & Lunn Investment Management Ltd. | 98,036 | $1.35M | 0.01% | −8,807−8.2% | Reduced |
| Bank of New York Mellon Corp | 98,307 | $1.36M | 0.00% | −7,422−7.0% | Reduced |
| Credit Suisse AG | 102,634 | $1.42M | 0.00% | −1,106−1.1% | Reduced |
| Ikarian Capital, LLC | 105,000 | $1.45M | 0.60% | +69,851+198.7% | Added |
| Allspring Global Investments Holdings, LLC | 106,868 | $1.48M | 0.00% | +7,019+7.0% | Added |
| SG Americas Securities, LLC | 113,114 | $1.56M | 0.02% | +113,114 | New |
| Pinnacle Associates Ltd | 113,770 | $1.57M | 0.03% | −724−0.6% | Reduced |
| Point72 Asset Management, L.P. | 127,300 | $1.76M | 0.01% | +50,800+66.4% | Added |
| Citadel Advisors LLC | 128,784 | $1.78M | 0.00% | +111,553+647.4% | Added |
| PDT Partners, LLC | 137,596 | $1.90M | 0.17% | +3,414+2.5% | Added |
| Raymond James Financial Services Advisors, Inc. | 153,068 | $2.11M | 0.00% | +2,355+1.6% | Added |
| Rafferty Asset Management, LLC | 153,193 | $2.12M | 0.02% | −74,650−32.8% | Reduced |
| Pictet Asset Management SA | 157,293 | $2.17M | 0.00% | +14,768+10.4% | Added |
| Massachusetts Financial Services Co | 157,510 | $2.17M | 0.00% | +795+0.5% | Added |
| Charles Schwab Investment Management Inc | 161,920 | $2.24M | 0.00% | −15,940−9.0% | Reduced |
| Fuller & Thaler Asset Management, Inc. | 165,310 | $2.28M | 0.02% | +1,100+0.7% | Added |
| Two Sigma Investments, LP | 204,154 | $2.82M | 0.01% | −311,295−60.4% | Reduced |
| Northern Trust Corp | 248,607 | $3.43M | 0.00% | −16,155−6.1% | Reduced |
| Citigroup Inc | 274,504 | $3.79M | 0.01% | +122,646+80.8% | Added |
| Quantedge Capital Pte Ltd | 289,600 | $4.00M | 0.81% | +246,800+576.6% | Added |
| Voloridge Investment Management, LLC | 312,476 | $4.32M | 0.02% | +11,263+3.7% | Added |
| Nuveen Asset Management, LLC | 317,511 | $4.38M | 0.00% | +194,584+158.3% | Added |
| JPMorgan Chase & Co | 324,980 | $4.49M | 0.00% | +19,539+6.4% | Added |
| Jupiter Asset Management Ltd | 327,553 | $4.52M | 0.06% | +10,341+3.3% | Added |
| Bank of America Corp | 329,596 | $4.55M | 0.00% | −92,844−22.0% | Reduced |
| Millennium Management LLC | 332,607 | $4.59M | 0.01% | −155,659−31.9% | Reduced |
| Goldman Sachs Group Inc | 367,535 | $5.08M | 0.00% | −111,388−23.3% | Reduced |
| Renaissance Technologies LLC | 393,400 | $5.43M | 0.01% | +178,200+82.8% | Added |
| EULAV Asset Management | 395,000 | $5.46M | 0.23% | −55,000−12.2% | Reduced |
| Geode Capital Management, LLC | 437,207 | $6.04M | 0.00% | +44,144+11.2% | Added |
| Two Sigma Advisers, LP | 442,800 | $6.12M | 0.02% | −134,400−23.3% | Reduced |
| Rockefeller Capital Management L.P. | 519,722 | $7.18M | 0.04% | +30,370+6.2% | Added |
| Samsara BioCapital, LLC | 640,688 | $8.85M | 2.37% | 00.0% | Unchanged |
| Macquarie Group Ltd | 645,069 | $8.91M | 0.01% | +24,398+3.9% | Added |
| Jacobs Levy Equity Management, Inc | 645,691 | $8.92M | 0.07% | +53,387+9.0% | Added |
| Eventide Asset Management, LLC | 800,000 | $11.0M | 0.24% | 00.0% | Unchanged |
| Morgan Stanley | 1,061,169 | $14.7M | 0.00% | +494,677+87.3% | Added |
| FMR LLC | 2,066,506 | $28.5M | 0.00% | −271,486−11.6% | Reduced |
| Vanguard Group Inc | 2,509,159 | $34.7M | 0.00% | +119,910+5.0% | Added |
| BlackRock Inc. | 2,718,354 | $37.5M | 0.00% | +63,097+2.4% | Added |
| State Street Corp | 3,476,632 | $48.0M | 0.00% | +254,800+7.9% | Added |
| International Biotechnology Trust PLC | 441 | – | – | +441 | New |
| Integral Health Asset Management, LLC | 0 | $0 | 0.00% | −125,000−100.0% | Sold out |
| Ci Investments Inc. | 0 | $0 | 0.00% | −123,736−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −55,700−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −47,466−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −34,745−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −26,836−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −22,300−100.0% | Sold out |
| Norges Bank | 0 | $0 | 0.00% | −17,294−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −17,258−100.0% | Sold out |
| CSS LLC | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −997−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −127−100.0% | Sold out |
| McCarthy Asset Management, Inc. | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| Parametric Portfolio Associates LLC | – | – | – | – | Not filed |
| Virginia Retirement Systems Et Al | – | – | – | – | Not filed |
| Susquehanna Fundamental Investments, LLC | – | – | – | – | Not filed |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |